JPMorgan Starts Dyne Therapeutics (DYN) at Overweight

October 12, 2020 5:51 AM EDT
Get Alerts DYN Hot Sheet
Price: $7.20 +4.80%

Rating Summary:
    5 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 4 | Down: 13 | New: 10
Join SI Premium – FREE

JPMorgan initiates coverage on Dyne Therapeutics (NASDAQ: DYN) with a Overweight rating and a price target of $27.00.


For an analyst ratings summary and ratings history on Dyne Therapeutics click here. For more ratings news on Dyne Therapeutics click here.


Shares of Dyne Therapeutics closed at $18.64 yesterday.


You May Also Be Interested In





Related Categories

New Coverage